Buy NAOV 20/10/2021 You can buy NAOV target 2.43 stop loss 1.48
Money management your responsibility.
I recommend entering a maximum of 10% of the portfolio.
Good luck
NAOV
NAOV BullishI think this company has potential for growth due to its reasonable price, new products, and expanding manufacturing. I think it could reach anywhere from 2.50 all the way up to about 10$ as the analyst target suggest. keep a close eye on this one, i loaded heavy just now. Biotec, pennys and growth stock season also suggest this will pump some.
$TAOP STRONG CLOSE!!! ;) -Traded this in the morning on friday but this failed to breakout that $4.25 wall that's #1 so the momentum is there but volume needs to kick in
-As we closed on friday we had a very strong close and candles like these don't get left hanging
-Tis is very strong resistance think of it like a rubber band the more you test its resistance the more it will shoot.
-This has massive potential you now the worse that can happen is that this is a pull back to more lows... set a tight stop play smart... theres basically no loss as long as you manage it correctly
NAOV Levels For MondayTaking a look at NAOV trading activity on Friday shows post-market action took the stock back up toward the 236 fib line from a retracement using 2019's highs of around 4.50. NAOV hit 3.61 around 6PM ET then got slammed lower, back down below the 382 fib line by the final bell. since that sits right around $3 that could be an important level to monitor if you're looking at NAOV heading into the week. This Fib level was also a previous area of resistance in Late 2019 and early 2021.
Something else to keep in mind is the upcoming proxy vote where the company will look to increase its authorized share count to 40 million. Either way, after such a huge parabolic move, it's going to be important to watch premarket action to see if NAOV can hold these levels at the start of the week.
$NAOV - Retracement & Trend Bullish - EMA To breakthrough Now NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.
SHORT INTEREST
23.96K 09/13/19
P/E Current
-4.56
P/E Ratio (with extraordinary items)
-3.15
Average Recommendation: BUY
Average Target Price: 10.50
